首页> 外文期刊>Biomedical materials >In vitro cytotoxicity and hemocompatibility studies of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys
【24h】

In vitro cytotoxicity and hemocompatibility studies of Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys

机译:Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf生物医学形状记忆合金的体外细胞毒性和血液相容性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The in vitro cytotoxicity and hemocompatibility of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf biomedical shape memory alloys (SMAs) were investigated by cell culture (L-929 fibroblast cell), hemolytic test and platelet adhesion test, with CP Ti as a reference material. The cytotoxicity test indicates that all the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs show over 94% cell viability for different incubation times (2, 4 and 7 days) in comparison with a negative control and CP Ti. The cell morphology observation shows good polygon-like adherent growth and proliferation of L-929 in the extracts of all the test samples and CP Ti. These results suggest excellent cytocompatibility for the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs. The hemolytic test reveals that the hemolysis ratios of the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf alloys are far less than 5%, so they cannot give rise to acute hemolysis. The platelet morphology observation shows almost the same adhered platelet morphology and activation ratio for the test samples in comparison with CP Ti, except the Ti-22Nb-6Hf alloy, which shows a lower activation ratio of platelets, indicating excellent blood compatibility. Therefore, it is proposed that the Ti-Nb, Ti-Nb-Zr and Ti-Nb-Hf SMAs will be candidates to replace Ti-Ni for biomedical applications.
机译:通过细胞培养(L-929成纤维细胞),溶血试验和血小板粘附试验研究了Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf生物医学形状记忆合金(SMA)的体外细胞毒性和血液相容性,以CP Ti为参考材料。细胞毒性测试表明,与阴性对照和CP Ti相比,所有Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf SMA在不同的孵育时间(2、4和7天)均显示超过94%的细胞活力。 。细胞形态观察表明,在所有测试样品和CP Ti的提取物中,L-929具有良好的多边形状粘附生长和增殖。这些结果表明,Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf SMA具有出色的细胞相容性。溶血试验表明,Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf合金的溶血率远小于5%,因此不会引起急性溶血。血小板形态观察结果显示,与CP Ti相比,测试样品的粘附血小板形态和活化率几乎相同,但Ti-22Nb-6Hf合金的血小板活化率较低,表明血液相容性极佳。因此,建议将Ti-Nb,Ti-Nb-Zr和Ti-Nb-Hf SMA替代生物医学应用中的Ti-Ni。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号